
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:title>The First Year&apos;s Experience with Large-Scale Use of Chlorpromazine and Reserpine in the Mental Hygiene Institutions of New York State: A Preliminary Report</dc:title>
  <dc:subject>Antipsychotic Agents</dc:subject>
  <dc:subject>Chlorpromazine</dc:subject>
  <dc:subject>Reserpine</dc:subject>
  <dc:subject>Tranquilizing Agents</dc:subject>
  <dc:description>Dr. Henry Brill, Assistant Commissioner of Mental Hygiene for New York State, testified before the House Appropriations Subcommittee on Labor regarding the promising new anti-psychotic drugs, chlorpromazine and reserpine, and the need to perform large-scale controlled studies with them. This was in support of Gorman&apos;s testimony on the same date.</dc:description>
  <dc:publisher>Produced: 16 February 1956</dc:publisher>
  <dc:contributor>Brill, Henry</dc:contributor>
  <dc:type>Speeches</dc:type>
  <dc:format>Archival Materials</dc:format>
  <dc:format>Text</dc:format>
  <dc:format>7 pages</dc:format>
  <dc:identifier>nlm:nlmuid-101743403X3-doc</dc:identifier>
  <dc:identifier>101743403X3</dc:identifier>
  <dc:identifier>http://resource.nlm.nih.gov/101743403X3</dc:identifier>
  <dc:identifier>Profiles ID: TGBBBD</dc:identifier>
  <dc:language>English</dc:language>
  <dc:relation>Profiles in Science</dc:relation>
</oai_dc:dc>